Lost password ?
<< Back to Equity Research
Dallah Healthcare
DALLAH HEALTHCARE PUSHED BY FAIRER WINDS
May 18 - In our last research paper on Dallah (Sell, Saudi Arabia), we went a bit far on our cautiousness. Both market and fundamental sides proved the other way round. The chart below (in pink) shows a stock ...
Executive summary
Conflict of Interest
Pages 38
Language English
Publish on May 18, 2021
€ 500
VAT Exl.
You might be also interested by these reports :
Apr 08 AM
Mouwasat Medical
Target pushed up by strong results
Mar 26 AM
Dallah Healthcare
Target boosted by a strong outlook
Mar 26 AM
Mouwasat Medical
Mouwasat Medical increases its net profit by 10%
Mar 15 AM
Dallah Healthcare
A slightly-weaker-than-expected Q4
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ